Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Annu Rev Med. 2023 Sep 20. doi: 10.1146/annurev-med-051322-120608. Online ahead of print.
ABSTRACT
Major depressive disorder (MDD) is a leading cause of suicide in the world. Monoamine-based antidepressant drugs are a primary line of treatment for this mental disorder, although the delayed response and incomplete efficacy in some patients highlight the need for improved therapeutic approaches. Over the past two decades, ketamine has shown rapid onset with sustained (up to several days) antidepressant effects in patients whose MDD has not responded to conventional antidepressant drugs. Recent preclinical studies have started to elucidate the underlying mechanisms of ketamine’s antidepressant properties. Herein, we describe and compare recent clinical and preclinical findings to provide a broad perspective of the relevant mechanisms for the antidepressant action of ketamine. Expected final online publication date for the Annual Review of Medicine, Volume 75 is January 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
PMID:37729028 | DOI:10.1146/annurev-med-051322-120608
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Ketamine: Mechanisms and Relevance to Treatment of Depression
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial The Use of Ketamine for the Treatment of Anhedonia in Depression A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder Up-to-Date on clinical and preclinical studies of psilocybin therapy A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) Curcumin and nano-curcumin applications in psychiatric disorders Antidepressant-associated diagnostic change from major depressive to bipolar disorder The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical study Current concepts in ketamine therapy in the emergency department Exploring the Impact of Music on Response to Ketamine/Esketamine: A Scoping Review Widespread reductions in cortical thickness following ketamine abuse Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo A meta-analysis of the effects of ketamine on suicidal ideation in depression patients Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report The role of BDNF transcription in the antidepressant-like effects of 18β-glycyrrhetinic acid in a chronic social defeat stress model The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality Is there evidence for using ketamine among individuals with dementia? Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled clinical trial protocol The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression Efficacy of Esketamine among patients with treatment resistant depression in a 'real world' health-care setting in Israel Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder Management of Depression in Adults: A Review Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring Antidepressant drug use after intensive care: a nationwide cohort study High-definition transcranial direct current stimulation (HD-tDCS) in major depressive disorder with anxious distress-a study protocol for a double-blinded randomized sham-controlled trial Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder Ketamine Self-Medication in a Patient with Autism Spectrum Disorder and Comorbid Therapy-Resistant Depression Ketamine Self-Medication in a Patient with Autism Spectrum Disorder and Comorbid Therapy-Resistant Depression Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review Long-term follow-up of participants in ketamine clinical trials for mood disorders Role of Electroconvulsive Therapy, Ketamine Infusion, and Deep Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression: A Case Report Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study Underlying mechanisms for psychotropic effects of delta opioid receptor agonists Ketamine Therapy in Complex Cases: A Cautionary Tale of Exacerbated Personality Traits and the Crucial Role of Comprehensive Follow-Up and Psychosocial Interventions Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol
Evidence Blueprint
Ketamine: Mechanisms and Relevance to Treatment of Depression
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Ketamine: Mechanisms and Relevance to Treatment of Depression
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects? Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics? The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial Role of klotho on antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression and suicidal ideation Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial Biological markers of sex-based differences in major depressive disorder and in antidepressant response The Use of Ketamine for the Treatment of Anhedonia in Depression A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: A randomized controlled trial Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study Up-to-Date on clinical and preclinical studies of psilocybin therapy A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation Randomized trial of ketamine masked by surgical anesthesia in patients with depression Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression Transcriptional signatures of early-life stress and antidepressant treatment efficacy Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies Ketamine use in pediatric depression: A systematic review cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies Ketamine, an Old-New Drug: Uses and Abuses Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst? Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis Network pharmacology and experimental evidence: ERK/CREB/BDNF signaling pathway is involved in the antidepressive roles of Kaiyu Zhishen decoction Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) Curcumin and nano-curcumin applications in psychiatric disorders Antidepressant-associated diagnostic change from major depressive to bipolar disorder Role of trazodone in treatment of major depressive disorder: an update The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical study Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder Current concepts in ketamine therapy in the emergency department Acute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-controlled Trial Efficacy of Transcranial Photobiomodulation on Depressive Symptoms: A Meta-Analysis Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice The prevalence and economic burden of treatment-resistant depression in Thailand Exploring the Impact of Music on Response to Ketamine/Esketamine: A Scoping Review Widespread reductions in cortical thickness following ketamine abuse Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study